From targeted monotherapy to combined BRAF–MEK inhibitors and integrated genome analysis for melanoma treatment

Author: Roukos Dimitrios H   Papaloukas Costas   Tzaphlidou Margaret  

Publisher: Future Medicine

ISSN: 1479-6694

Source: Future Oncology, Vol.9, Iss.1, 2013-01, pp. : 5-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract